| Literature DB >> 26520791 |
So-Phia Chew1, Shu-Ling Chong2, Sylvaine Barbier3, Aji Matthew4, Jan Hau Lee5, Yoke Hwee Chan6.
Abstract
BACKGROUND: Hand foot mouth disease (HFMD) is a common childhood infection that can potentially lead to serious complications. The aim of this study is to identify risk factors of acquiring severe HFMD in our population.Entities:
Mesh:
Year: 2015 PMID: 26520791 PMCID: PMC4628372 DOI: 10.1186/s12879-015-1195-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Demographic data and presenting history
| Cases ( | Controls ( | OR (95 % CI) |
| |
|---|---|---|---|---|
| Demographics | ||||
| Age (year) median (IRQ) | 3.0 (1.5;5.5) | 2.5 (1;5.5) | 1.04 (0.70;1.55) | 0.848 |
| Female | 15 (63 %) | 26 (54 %) | 0.72 (0.27;1.92) | 0.506 |
| Presenting History | ||||
| Level of fever (°C) ( | 39 (38.7;39.4) | 39 (38.5;39.5) | 1.06 (0.49;2.25) | 0.888 |
| Temperature ≥ 39 °C | 17 (74 %) | 24 (57 %) | 2.19 (0.69;6.96) | 0.183 |
| Temperature < 39 °C | 6 (26 %) | 18 (43 %) | ||
| Duration of fever (days) | 3.3 (2.0) | 2.4 (1.6) | 1.27 (0.97;1.67) | 0.077 |
| Contact history ( | 13 (57 %) | 20 (42 %) | 1.94 (0.65;5.79) | 0.236 |
| Vomiting | 10 (42 %) | 16 (33 %) | 1.42 (0.52;3.86) | 0.494 |
| Symptoms of hypoperfusionc | 11 (46 %) | 8 (17 %) | NC | 0.012b |
| Seizure | 12 (50 %) | 1 (2 %) | NC | <0.001b |
| Altered mentation | 8 (33 %) | 3 (6 %) | 13.11 (1.61;106.60) | 0.016 |
NC non-computable
afrom conditional logistic regression
bfrom Fisher’s exact test
cas characterized by lethargy, syncope or reported cool extremities
Vital signs at presentation
| Initial vital signs | Cases ( | Controls ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | OR (95 % CI) |
| |||||||
| <1 year | 1- 4.99 years | 5-9.99 years | >10 years | <1 year | 1- 4.99 years | 5-9.99 years | >10 years | |||
|
|
|
|
|
|
|
|
| |||
| Heart rate (beats/min) | 184 (170;200) | 152 (131;173) | 115(104;119) | 117 (81;153) | 146 (120;178) | 123 (109;157) | 112 (109;120) | 109.5 (86.5;116.0) | 1.02 (1.00;1.05) | 0.021 |
| Respiratory rate (breath/min) | 40 (36;46) | 30 (26;32) | 25 (22;28) | 31 (18;44) | 35 (34;38) | 30 (24;30) | 20 (20;22) | 20 (18;21) | 1.15 (1.01;1.29) | 0.03 |
| Systolic blood pressure (mmHg) ( | 100 (75;111) | 106 (96;118) | 114 (91;121) | 120.5 (108;133) | 106 (87;110) | 100 (87;108) | 107.5 (100.0;129.0) | 114 .0(104.5;115.5) | 1.03 (0.99;1.07) | 0.16 |
| Diastolic blood pressure (mmHg) ( | 50 (49;67) | 64.5(53.0;78.0) | 65 (60;71) | 65 (62;68) | 54 (46;63) | 65 (58;70) | 66 (57;68) | 68.5 (63.5;73) | 1.01 (0.96;1.05) | 0.819 |
| Pulse oximetry reading (%) | 97 (96;100) | 98.5 (98.0;100.0) | 100 (100;100) | 96.5 (95;98.5) | 100 (99;100) | 99 (98;100) | 99 (99;99) | 100 (99;100) | 0.69 (0.48;0.97) | 0.032 |
| Temperature on arrival (°C) | 38.40 (37.90;39.50) | 38.55 (37.40;39.10) | 36.3 (36.3;37.6) | 36.8 (36.5;37.1) | 38.05 (37.4;38.0) | 37.20 (36.85;37.95) | 37.85 (37.1;38.9) | 37 (36.7;37.1) | 1.32 (0.84;2.09) | 0.227 |
aNo documented blood pressure for 2 controls
Clinical signs at presentation
| Cases ( | Controls ( |
| |
|---|---|---|---|
| GCS < 15 at presentation | 7 (29 %) | 0 (0 %) | <0.001 |
| Deterioration in GCSa | 4 (17 %) | 0 (0 %) | 0.010 |
| Seizure on arrival | 6 (25 %) | 0 (0 %) | 0.001 |
| Altered mentation | 11 (46 %) | 0 (0 %) | <0.001 |
| Poor peripheral perfusion | 8 (33 %) | 0 (0 %) | <0.001 |
| Distribution of rash and presence of ulcers ( | |||
| Typical hands and feet rash and oral ulcers | 15 (63 %) | 41 (85 %) | 0.037 |
| Absence of oral ulcers | 6 (25 %) | 4 (8 %) | 0.066 |
| Meningeal irritation | 4 (17 %) | 0 (0 %) | 0.010 |
aAny drop in GCS
Results of investigations
| Investigations | Cases ( | Controls ( | OR (95 % CI) |
|
|---|---|---|---|---|
| Initial Full Blood Count ( | ||||
| Total white cell count, median (IQR) | 14.54 (11.0; 18.20) | 8.27 (7.02;8.27) | 1.36 (1.11;1.66) | 0.003 |
| Absolute neutrophil count, median (IQR) | 9.08 (6.51;12.09) | 4.49 (3.37;4.49) | 1.38 (1.11;1.71) | 0.004 |
| Absolute lymphocyte count, median (IQR) | 2.81(2.39;4.43) | 2.60(2.07;2.60) | 1.28 (0.89;1.85) | 0.18 |
| EV-A71 Status | ||||
| Positive | 9/24 (38 %) | 7/48 (15 %) | 10.28 (1.24;85.21) | 0.031 |
| Stool N (%)a | 2/9 (22 %) | 1/7 (14 %) | ||
| Throat swab N (%)a | 8/9 (89 %) | 7/7 (100 %) | ||
| CSF N (%)a | 0/9 (0 %) | 0/9 (0 %) |
aNumbers are accounted for because some patients had more than 1 specimen site tested